These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31843010)

  • 21. Low frequency of mtDNA point mutations in patients with PEO associated with POLG1 mutations.
    Kollberg G; Jansson M; Pérez-Bercoff A; Melberg A; Lindberg C; Holme E; Moslemi AR; Oldfors A
    Eur J Hum Genet; 2005 Apr; 13(4):463-9. PubMed ID: 15702133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment of deleterious variants of mitochondrial DNA polymerase gene (POLG1) in bipolar disorder.
    Kasahara T; Ishiwata M; Kakiuchi C; Fuke S; Iwata N; Ozaki N; Kunugi H; Minabe Y; Nakamura K; Iwata Y; Fujii K; Kanba S; Ujike H; Kusumi I; Kataoka M; Matoba N; Takata A; Iwamoto K; Yoshikawa T; Kato T
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):518-529. PubMed ID: 27987238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. POLG1 polyglutamine tract variants associated with Parkinson's disease.
    Eerola J; Luoma PT; Peuralinna T; Scholz S; Paisan-Ruiz C; Suomalainen A; Singleton AB; Tienari PJ
    Neurosci Lett; 2010 Jun; 477(1):1-5. PubMed ID: 20399836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POLG1-related levodopa-responsive parkinsonism.
    Miguel R; Gago MF; Martins J; Barros P; Vale J; Rosas MJ
    Clin Neurol Neurosurg; 2014 Nov; 126():47-54. PubMed ID: 25203713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile onset Parkinsonism with "pure nigral" degeneration and POLG1 mutation.
    Mehta SH; Dickson DW; Morgan JC; Singleton AB; Majounie E; Sethi KD
    Parkinsonism Relat Disord; 2016 Sep; 30():83-5. PubMed ID: 27349602
    [No Abstract]   [Full Text] [Related]  

  • 27. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
    Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
    Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
    Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J
    Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene.
    Delgado-Alvarado M; de la Riva P; Jiménez-Urbieta H; Gago B; Gabilondo A; Bornstein B; Rodríguez-Oroz MC
    J Neurol Sci; 2015 Mar; 350(1-2):93-7. PubMed ID: 25724872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.
    Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM
    Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apraxia of lid opening mimicking ptosis in compound heterozygosity for A467T and W748S POLG1 mutations.
    Paus S; Zsurka G; Baron M; Deschauer M; Bamberg C; Klockgether T; Kunz WS; Kornblum C
    Mov Disord; 2008 Jul; 23(9):1286-8. PubMed ID: 18546343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DNA polymerase gamma Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine.
    Graziewicz MA; Bienstock RJ; Copeland WC
    Hum Mol Genet; 2007 Nov; 16(22):2729-39. PubMed ID: 17725985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midbrain dopamine neuron differentiation: factors and fates.
    Abeliovich A; Hammond R
    Dev Biol; 2007 Apr; 304(2):447-54. PubMed ID: 17331494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
    Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
    J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons
    Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
    J Neurosci; 2018 Feb; 38(7):1662-1676. PubMed ID: 29321139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia.
    Lamantea E; Tiranti V; Bordoni A; Toscano A; Bono F; Servidei S; Papadimitriou A; Spelbrink H; Silvestri L; Casari G; Comi GP; Zeviani M
    Ann Neurol; 2002 Aug; 52(2):211-9. PubMed ID: 12210792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. POLG1 Arg953Cys mutation: expanded phenotype and recessive inheritance in a Brazilian family.
    Gurgel-Giannetti J; Camargos ST; Cardoso F; Hirano M; DiMauro S
    Muscle Nerve; 2012 Mar; 45(3):453-4. PubMed ID: 22334187
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymerase gamma 1 mutations: clinical correlations.
    Milone M; Massie R
    Neurologist; 2010 Mar; 16(2):84-91. PubMed ID: 20220442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hereditary Parkinson’s disease as a new clinical manifestation of the damaged POLG gene].
    Illés A; Balicza P; Gál A; Pentelényi K; Csabán D; Gézsi A; Molnár V; Molnár MJ
    Orv Hetil; 2020 May; 161(20):821-828. PubMed ID: 32364361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.